Skip to content

Development of MRI technology for improved visualization and quantification of tissue and organs in healthy volunteers

Development of MRI technology for improved visualization and quantification of tissue and organs in healthy volunteers - Development of MRI technology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON47106
Enrollment
500
Registered
2014-05-01
Start date
2014-02-02
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gezond tissues and organs

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Healthy subject (defined as a volunteer who is not referred to Erasmus MC with signs and symptoms of disease) - At least 18 years old - Signed informed consent

Exclusion criteria

Exclusion criteria: - Subjects with a typical contra-indication to an MRI exam. - Subjects with metal implants. - Subjects who have a documented allergy to MRI contrast media or a contra-indication for - contrast-media are eligible for MRI, but will not undergo contrast-enhanced MRI. - Woman who are pregnant or lactating - Having any physical or mental status that interferes with the informed consent procedure

Design outcomes

Primary

MeasureTime frame
Generally, data will be collected and analysis techniques will be used as appropriate for the specific project and its purpose. The following parameters are likely to be collected: * Overall Image quality and (physiological) artifacts will be ranked on a five point scale. * SNR and CNR (lesion versus background) will be measured. * Calculation of quantitative parameter values (e.g. T1, T2) when relevant.

Secondary

MeasureTime frame
* If applicable, the reproducibility of derived quantitative parameters will be asessed, and these parameters will be compared with reference values from literature (if available) or with reference values derived from standard clinical MR series. * If applicable, the results of (semi-)automated image post-processing techniques will be compared with manual annotations in terms of accuracy, reproducibility, and robustness. * If applicable, the presence of false positives or false negatives (using the standard clinical MR series as ground truth) will be assessed. * If applicable, workflow aspects will be documented and analyzed.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)